3:45 PM
Sep 06, 2018
 |  BC Extra  |  Company News

Management tracks: Rheos, Aileron

Immunometabolism company Rheos Medicines Inc. (Cambridge, Mass.) hired Sanjay Keswani as CEO. He was SVP and global head of neuroscience, ophthalmology and rare disease for the Pharma Research and Early Development (pRED) group at Roche (SIX:ROG; OTCQX:RHHBY). Keswani succeeds Interim CEO Abbie Celniker, who will remain as Rheos' chairman. She is a partner at Third...

Read the full 254 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >